Table 1.
Lipids | MRM transitions | Lipids | MRM transitions | ||
---|---|---|---|---|---|
PA 16:0/18:3 | 669.43 | 255 | PS 18:3/18:3 | 778.45 | 277 |
PA 16:0/18:2 | 671.4 | 255 | PS 18:3/18:2 | 780.37 | 277 |
PA 16:0/18:1 | 673.46 | 255 | PS 18:1/18:3 | 782.48 | 277 |
PA 18:3/18:3 | 691.47 | 277 | PS 18:1/18:2 | 784.51 | 279 |
PA 18:3/18:2 | 693.4 | 279 | PS 18:1/18:1 | 786.57 | 281 |
PA 18:3/18:1 | 695.45 | 277 | PS 18:0/18:1 | 788.49 | 283 |
PA 18:1/18:2 | 697.44 | 279 | PS 18:0/18:0 | 790.57 | 283 |
PA 18:1/18:1 | 699.42 | 281 | PC 16:0/18:2 | 802.5 | 279 |
PA 18:1/18:0 | 701.58 | 283 | PC 16:0/18:1 | 804.5 | 255 |
PE 16:0/18:2 | 714.7 | 279 | PC 16:0/18:0 | 806.5 | 255 |
PE 16:0/18:1 | 716.68 | 255 | PC 18:2/18:3 | 824.5 | 279 |
PE 18:2/18:3 | 736.52 | 279 | PC 18:2/18:2 | 826.5 | 279 |
PE 18:1/18:3 | 738.7 | 277 | PC 18:1/18:2 | 828.5 | 279 |
PE 18:2/18:2 | 738.7 | 279 | PC 18:0/18:2 | 830.5 | 279 |
PE 18:1/18:2 | 740.69 | 279 | PC 18:1/18:1 | 830.53 | 281 |
PE 18:1/18:1 | 742.73 | 281 | PI 16:0/18:3 | 831.65 | 255 |
PE 18:1/18:0 | 744.66 | 281 | PI 16:0/18:2 | 833.6 | 255 |
PE 18:2/20:1 | 768.58 | 279 | PI 16:0/18:1 | 835.73 | 255 |
PE 18:1/20:1 | 770.54 | 281 | PI 18:3/18:3 | 853.5 | 277 |
PG 16:0/18:3 | 743.53 | 277 | PI 18:2/18:3 | 855.66 | 277 |
PG 16:0/18:2 | 745.53 | 279 | PI 18:2/18:2 | 857.55 | 279 |
PG 16:0/18:1 | 747.53 | 281 | PI 18:1/18:2 | 859.55 | 279 |
PS 16:0/18:3 | 756.46 | 255 | PI 18:1/18:1 | 861.56 | 281 |
PS 16:0/18:2 | 758.46 | 255 | PI 18:0/18:1 | 863.59 | 281 |
PS 16:0/18:1 | 760.57 | 255 |
The species which were used in quantitative analysis in this paper have been marked in italics
PA phosphatidic acid, PC phosphatidylcholine, PE phosphatidylethanolamine, PG phosphatidylglycerol, PI phosphatidylinositol, PS phosphatidylserine